Early Access — free while we kick the tires
EdgarHawk

STEPHENSON ROBERT O

CHIEF FINANCIAL OFFICER

Officer
2 filings analyzed · 1 company · Latest 2024-10-01

Companies

Company Buys Sells Direction
OMEGA HEALTHCARE INVESTORS INC OHI 0 2 Net selling

Activity

October 2024
medium
Sell
22,542 shares
$905,963
Significance 5/10

CFO Robert O Stephenson sold 22,542 shares of OHI at $40.19 for $905,962.98 on 2024-09-27; retains 183,076 shares.

Robert O Stephenson, Chief Financial Officer of Omega Healthcare Investors Inc, sold 22,542 shares on 2024-09-27 at $40.19, reducing his holdings by 11.0% to 183,076 shares post-transaction. The sale occurred near the 52-week high of $41.29, with the stock currently at $40.39 and up 19.5% over 90 days. Stephenson's cross-ticker track record shows 1 prior sell with an average 30-day return of +5.9%, though his timing pattern across all trades shows no measurable well-timed sells at the 90-day mark, limiting inference about predictive skill. The company reports strong fundamentals with $252.7M quarterly revenue, $117.1M net income, and 8.1% annual revenue growth, though a P/E of 30.83 reflects elevated valuation relative to historical context.

August 2024
Sell
30,000 shares
$1,163,520
Significance 4/10

OHI CFO Stephenson sells 30,000 shares at $38.78; retains 205,618 shares post-sale.

Chief Financial Officer Robert O. Stephenson sold 30,000 shares of Omega Healthcare Investors on 2024-08-26 at $38.78, reducing his holdings by 12.7% to 205,618 shares. The sale occurred near the 52-week high of $39.27, with the stock having appreciated 8.2% over the prior 30 days and 27.6% over 90 days. The company reports strong fundamentals: $252.7M in latest quarterly revenue, $117.1M in net income, and 8.1% annual revenue growth, with a market cap of $10.1B. No FLAGS indicating a scheduled trading plan are present in the filing facts, suggesting this was a discretionary transaction by the CFO at a price point within the upper range of recent performance.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access